
- Telehealth Visits
- Insurance plan information

Jonathan Lu, MD
Ophthalmology (Ophthalmic Plastic and Reconstructive Surgery)- Telehealth Visits
- Insurance plan information



Jonathan Lu, MD
Ophthalmology (Ophthalmic Plastic and Reconstructive Surgery)- Telehealth Visits
- Insurance plan information
On this page
Education & training
Board certification
- Ophthalmology, American Board of Ophthalmology
Fellowship
- Oculoplastic Surgery, Massachusetts Eye and Ear Infirmary
Residency
- Ophthalmology, University of Southern California- Los Angeles
Internship
- Transitional, Memorial Sloan Kettering Cancer Center (GME)
Degree
- MD, University of California Davis School of Medicine
Academic title
- Clinical Professor
My expertise
Locations
My research
Publications
Showing 1-6 of 106 reviews
- July 16, 20265 out of 5 Stars
Excelllent
- July 7, 20265 out of 5 Stars
The excellence we receive from Dr Jonathon Lu is always amazing. We understand and appreciate the privilege we enjoy as one of his many patients. God grant him long life and unspeakable joy in his divinely appointed task offering years to our life and life to our years.
- June 27, 20264.6 out of 5 Stars
Dr. Lu was very helpful in answering my questions and understanding my current health issues to assist me in making decisions. He is very thoughtful and skilled doctor.
- June 17, 20265 out of 5 Stars
I would recommend the attention is very good I gradesco because everything they have helped me
- June 14, 20265 out of 5 Stars
Good
- May 19, 20265 out of 5 Stars
As always, very caring. Astute patient
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.